Your browser doesn't support javascript.
loading
Galactomannan Is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis.
Gebremariam, Teclegiorgis; Alkhazraji, Sondus; Gu, Yiyou; Singh, Shakti; Alqarihi, Abdullah; Shaw, Karen Joy; Ibrahim, Ashraf S.
Afiliação
  • Gebremariam T; The Lundquist Institute for Biomedical Innovations, Torrance, California, USA.
  • Alkhazraji S; The Lundquist Institute for Biomedical Innovations, Torrance, California, USA.
  • Gu Y; The Lundquist Institute for Biomedical Innovations, Torrance, California, USA.
  • Singh S; The Lundquist Institute for Biomedical Innovations, Torrance, California, USA.
  • Alqarihi A; The Lundquist Institute for Biomedical Innovations, Torrance, California, USA.
  • Shaw KJ; Amplyx Pharmaceuticals Inc., San Diego, California, USA kshaw@amplyx.com ibrahim@lundquist.org.
  • Ibrahim AS; The Lundquist Institute for Biomedical Innovations, Torrance, California, USA kshaw@amplyx.com ibrahim@lundquist.org.
Antimicrob Agents Chemother ; 64(1)2019 12 20.
Article em En | MEDLINE | ID: mdl-31685475
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Aspergilose Pulmonar Invasiva / Mananas / Antifúngicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Aspergilose Pulmonar Invasiva / Mananas / Antifúngicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article